Rite Aid (RAD) intends to dispense the abortion pill in a "limited number" of its stores two weeks after competitors Walgreens Boots Alliance (WBA) and CVS Health (CVS) said they would get certified to provide the pill to patients, Bloomberg’s Fiona Rutherford reports. A company spokesperson said that Rite Aid seeks to sell the pill, mifepristone, to customers either in-person or by mail delivery in compliance with federal and state rules. "We are committed to ensuring equitable access to customers prescribed this product," the spokesperson said. Reference Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on RAD:
- Rite Aid ‘bears watching’ after CEO exit, Dealreporter says
- Unusually active option classes on open January 9th
- Rite Aid backs FY23 revenue view $23.7B-$24B, consensus $21.63B
- Rite Aid appoints Elizabeth Burr as interim CEO
- Short Report: Bears pounce on disappointing drug news from Gossamer and Verve